Alkermes Plc (ALKS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALKS | AMGN | GILD | CELG | VRTX |
| Company | Alkermes Plc | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 28.26 | 337.03 | 84.39 | 108.01 | 477.70 |
| High | 28.35 | 337.81 | 84.61 | 108.59 | 478.99 |
| Low | 28.06 | 334.61 | 83.93 | 107.27 | 477.31 |
| Last | 28.15 | 338.03 | 84.08 | 108.24 | 478.40 |
| Change | +0.32 | +5.11 | +0.19 | +0.11 | +4.24 |
| % Change | +1.15% | +1.53% | +0.23% | +0.10% | +0.89% |
| Volume | 38,561 | 54,589 | 581,924 | 191,230,496 | 33,916 |
| 20-Day Average Volume | 1,287,023 | 1,682,104 | 6,284,116 | 16,188,930 | 941,731 |
| Previous Close | 27.83 | 332.92 | 83.89 | 108.13 | 474.16 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 27.69 | 329.63 | 80.08 | 108.17 | 479.90 |
| 20-Day Raw Stochastic | 81.44% | 88.70% | 91.09% | 63.25% | 45.25% |
| 20-Day Relative Strength | 57.75% | 58.25% | 72.14% | 64.69% | 49.72% |
| Weighted Alpha | +2.58 | +27.51 | +18.51 | +46.30 | +33.81 |
| Today's Opinion | 72% Buy | 96% Buy | 88% Buy | 100% Buy | 40% Buy |
| Previous Opinion | 72% Buy | 88% Buy | 88% Buy | 100% Buy | 40% Buy |
| Last Month's Opinion | 56% Buy | 88% Buy | 56% Buy | 100% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.89% since 09/12/24 | +2.02% since 09/12/24 | +1.06% since 09/12/24 | -1.97% since 11/13/19 | -0.01% since 09/12/24 |
| Low | 26.75 on 09/13/24 | 327.15 on 09/13/24 | 81.57 on 09/13/24 | 107.27 on 11/20/19 | 473.75 on 09/18/24 |
| High | 28.47 on 09/17/24 | 339.00 on 09/18/24 | 84.61 on 09/19/24 | 110.53 on 11/14/19 | 490.15 on 09/16/24 |
| 1-Month | |||||
| %Chg | -0.37% since 08/19/24 | +2.67% since 08/19/24 | +12.88% since 08/19/24 | +5.14% since 10/18/19 | -1.94% since 08/19/24 |
| Low | 25.65 on 09/10/24 | 319.00 on 09/06/24 | 74.34 on 08/20/24 | 102.40 on 10/21/19 | 460.69 on 09/11/24 |
| High | 28.69 on 08/27/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 500.25 on 08/30/24 |
| 3-Month | |||||
| %Chg | +15.17% since 06/18/24 | +10.05% since 06/18/24 | +33.08% since 06/18/24 | +13.63% since 08/20/19 | +2.42% since 06/18/24 |
| Low | 22.90 on 07/10/24 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 93.41 on 08/23/19 | 458.04 on 08/13/24 |
| High | 28.95 on 07/26/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 510.64 on 08/01/24 |
| 6-Month | |||||
| %Chg | +1.53% since 03/19/24 | +23.92% since 03/19/24 | +14.48% since 03/19/24 | +14.14% since 05/20/19 | +15.27% since 03/19/24 |
| Low | 22.90 on 07/10/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 89.08 on 07/23/19 | 391.01 on 04/18/24 |
| High | 28.95 on 07/26/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 510.64 on 08/01/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,709,421 | 178,589,936 | 104,514,608 | 77,035,920 | 122,358,416 |
| Shares Outstanding, K | 169,221 | 536,435 | 1,245,853 | 711,714 | 258,053 |
| Annual Sales | 1,663,410,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,869,200,000 |
| Annual Net Income | 355,760,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 3,619,600,000 |
| Last Quarter Sales | 399,130,000 | 8,388,000,000 | 6,954,000,000 | 4,520,000,000 | 2,645,600,000 |
| Last Quarter Net Income | 91,360,000 | 746,000,000 | 1,614,000,000 | 1,691,000,000 | -3,593,600,000 |
| 60-Month Beta | 0.46 | 0.61 | 0.18 | 1.41 | 0.40 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.72 on 07/24/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | 2.99 on 10/31/19 | -12.83 on 08/01/24 |
| Latest Earnings Date | 10/23/24 | 10/29/24 | 11/05/24 | 10/31/19 | 11/04/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 09/13/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 16.03 | 17.89 | 17.67 | 10.99 | 0.00 |